PROPRANOLOL VIATRIS propranolol hydrochloride 40 mg tablet bottle

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

propranolol hydrochloride, Quantity: 40 mg

Disponibbli minn:

Alphapharm Pty Ltd

INN (Isem Internazzjonali):

Propranolol hydrochloride

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: sunset yellow FCF aluminium lake; maize starch; lactose monohydrate; povidone; brilliant blue FCF aluminium lake; sodium starch glycollate; magnesium stearate; quinoline yellow

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

100

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Angina pectoris; Hypertension; Prevention of migraine; Cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline (epinephrine overdosage); Essential tremor, including familial and senile tremor; Phaeochromocytoma (only with concurrent alpha-receptor blockade); Hypertrophic subaortic stenosis; Suspected or definite myocardial infarction; Fallot?s Tetralogy

Sommarju tal-prodott:

Visual Identification: Green coloured, round, biconvex tablets, embossed with "P" and "40" on either side of the breakline on one side and plain on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2015-02-13